Related references
Note: Only part of the references are listed.A National Survey on the Use of Electronic Directly Observed Therapy for Treatment of Tuberculosis
Michelle Macaraig et al.
JOURNAL OF PUBLIC HEALTH MANAGEMENT AND PRACTICE (2018)
Use of Video Directly Observed Therapy for Treatment of Latent Tuberculosis Infection — Johnson County, Kansas, 2015
Elizabeth Lawlor Holzschuh et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2017)
Self-administered Versus Directly Observed Once-Weekly Isoniazid and Rifapentine Treatment of Latent Tuberculosis Infection A Randomized Trial
Robert Belknap et al.
ANNALS OF INTERNAL MEDICINE (2017)
Treatment for Tuberculosis Infection With 3 Months of Isoniazid and Rifapentine in New York City Health Department Clinics
Natalie L. Stennis et al.
CLINICAL INFECTIOUS DISEASES (2016)
Digital health for the End TB Strategy: developing priority products and making them work
Dennis Falzon et al.
EUROPEAN RESPIRATORY JOURNAL (2016)
Enhancing management of tuberculosis treatment with video directly observed therapy in New York City
C. Chuck et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2016)
Feasibility of tuberculosis treatment monitoring by video directly observed therapy: a binational pilot study
R. S. Garfein et al.
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2015)
Home Videophones Improve Direct Observation in Tuberculosis Treatment: A Mixed Methods Evaluation
Victoria A. Wade et al.
PLOS ONE (2012)
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
Timothy R. Sterling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Treatment of latent tuberculosis infection: An update
Philip Lobue et al.
RESPIROLOGY (2010)